Fortune January 10, 2024
Bloomberg—U.S. regulators gave temporary permission for importation of a form of penicillin used to treat syphilis amid a national shortage of Pfizer Inc.’s version of the drug along with a dramatic increase in cases.
The Food and Drug Administration authorized importation of penicillin G benzathine made by a French company, Laboratoires Delbert, according to the agency website. Pfizer’s Bicillin L-A, the only version of the drug available in the U.S., has been in short supply since April.
Penicillin G benzathine is the preferred treatment for syphilis and the only medication for the congenital form of the disease, which killed hundreds of babies and fetuses in 2022. After rates skyrocketed to levels not seen since the 1990s, the U.S. stood up...
Today's Sponsors
Today's Sponsor